This present study assessed the antihypertensive efficacy of the fixed combination of
manidipine and delapril by ambulatory blood pressure monitoring in patients with …

Objective: We investigated whether the long-half time dihydropyridine calcium-channel
blocker amlodipine was more efficacious than the gastrointestinal therapeutic system (GITS) …

Study Objective. To evaluate the efficacy and safety of a new combination product, enalapril‐
diltiazem ER, when administered over the long term. Design. Open‐label, titration to …

In a 3‐month, open‐label study, 54 consecutive black patients with very severe hypertension
were treated with amlodipine. Very severe hypertension was defined as an average sitting …

Although the effectiveness of diltiazem for the treatment of patients with hypertension has
been well demonstrated in numerous placebo-controlled and comparative clinical trials …

Data from a long-term, open-label diltiazem trial were analyzed to test the hypothesis that
the magnitude of systolic blood pressure (SBP) response to diltiazem is dependent on …

A double-blind, parallel, comparative evaluation of amlodipine against captopril in the
monotherapeutic treatment of mild and moderate essential hypertension: interim results …

In a double-blind, parallel, 12-week trial, antihypertensive effects of diltiazem and reserpine
were compared in 107 patients with essential hypertension. Diltiazem reduced blood …

Once-daily administration of amlodipine, a long-acting dihydropyridine calcium-channel
blocker, and atenolol, a cardioselective [beta]-adrenoceptor blocking agent, were compared …

A multicenter, placebo-controlled trial assessed the antihypertensive efficacy and safety of
different doses of amlodipine in patients with mild to moderate hypertension. Amlodipine …